Key Takeaways
- Despite a trailing P/E of 226x, Palantir’s PEG ratio of 0.964 technically indicates the stock is undervalued relative to its growth rate.
- UBS analysts upgraded their price target to $200 from $180 while keeping their buy recommendation, suggesting approximately 36% potential upside.
- The stock has declined 13% in 2026 year-to-date, even after climbing more than 500% over the previous five-year period.
- Management’s 2026 full-year revenue forecast of $7.18–$7.20 billion points to approximately 61% year-over-year growth, exceeding previous analyst estimates.
- Fourth-quarter 2025 U.S. commercial revenue jumped 137% compared to the prior year, while the company achieved a record “rule of 40” metric of 127%.
Palantir Technologies (PLTR) is currently trading in the $147–$148 range per share.
Palantir Technologies Inc., PLTR
For years, analysts have flagged Palantir as among the most richly valued technology companies. With a trailing price-to-earnings multiple of 226x, that reputation seems justified at first glance. However, examining a different valuation metric — the price/earnings-to-growth (PEG) ratio — reveals a potentially different investment thesis.
Palantir’s PEG ratio stands at 0.964 currently. Traditional valuation theory suggests that readings under 1.0 indicate potential undervaluation. The mathematics behind this are straightforward: the company delivered 232% earnings-per-share growth year-over-year in 2025. When that extremely high P/E is divided by such robust growth, the resulting figure compresses significantly.
This dramatic EPS expansion was fueled substantially by expanding profit margins — which surged from 10% in the fourth quarter of 2024 to 43% in Q4 2025. Such margin improvement represents an exceptional, likely non-repeatable event. While margins may continue trending upward, another fourfold expansion isn’t realistic.
UBS Analysts Boost Price Target to $200
With PLTR shares down 13% in 2026 so far, UBS released a significant research update this week — increasing their price target from $180 to $200 while reaffirming their buy rating. This new target implies roughly 36% appreciation potential from current trading levels.
UBS has characterized Palantir as representing a “premier growth story” in prior research reports. The target increase came on the heels of another impressive quarterly performance: the company delivered Q4 EPS of $0.25, beating the $0.23 consensus estimate, alongside revenue of $1.41 billion — representing 70% year-over-year expansion.
The more significant driver may have been management’s February guidance update. Leadership projected first-quarter 2026 revenue between $1.532–$1.536 billion and full-year 2026 revenue in the $7.18–$7.20 billion range. This would translate to approximately 61% annual revenue growth, substantially exceeding the prior consensus estimate of roughly $1.31 billion for Q1.
During Q4 2025, Palantir secured 180 contracts valued at a minimum of $1 million each, with 61 of those exceeding $10 million. The company’s U.S. commercial segment posted 137% year-over-year revenue growth for the quarter.
AIP Bootcamp Strategy Accelerates Sales Cycles
Central to Palantir’s 2026 growth trajectory is its approach to acquiring enterprise customers. The company’s AIP bootcamp methodology aims to condense AI solution sales cycles from several months down to just days — moving prospects from initial demonstration through to live deployment far more rapidly than conventional enterprise software implementations.
The company recorded a “rule of 40” metric of 127% in Q4 2025, representing an all-time peak and demonstrating the powerful combination of accelerating revenue growth paired with strong profitability.
Looking toward 2026, the investment case is straightforward: Palantir’s market valuation has shifted from pricing in future possibility to pricing in demonstrated performance. UBS’s updated $200 price target signals conviction that bootcamp conversion rates and commercial business momentum can be sustained.
The current Wall Street analyst consensus shows an average price target of $187, implying approximately 27% upside from present trading levels.
